Related Experiment Video
Updated: Jun 18, 2026
13:20
Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
CYT997 causes apoptosis in human multiple myeloma
Katherine Monaghan1, Tiffany Khong, Gregg Smith
1Myeloma Research Group, Malignant Haematology and Stem Cell Transplantation, South Block, Alfred Hospital, Prahran, Victoria, Australia.
Investigational New Drugs
|November 13, 2009
Summary
The novel agent CYT997 shows significant promise for treating multiple myeloma (MM). This microtubule targeting agent (MTA) effectively kills myeloma cells and enhances bortezomib
Area of Science:
- Oncology
- Pharmacology
Background:
- Multiple Myeloma (MM) is a fatal plasma cell malignancy.
- Microtubule targeting agents (MTAs) are a key therapeutic class for MM.
Purpose of the Study:
- To investigate the anti-myeloma activity of the novel tubulin polymerization inhibitor CYT997.
- To evaluate CYT997's efficacy alone and in combination with bortezomib.
Main Methods:
- In vitro studies using human myeloma cell lines (HMCLs) and primary MM cells.
- In vivo studies using a murine model of systemic myelomatosis.
Main Results:
- CYT997 demonstrated potent anti-myeloma activity at nanomolar concentrations, inducing tubulin disruption, growth inhibition, cell cycle arrest, and apoptosis.
- CYT997 synergized with bortezomib to enhance anti-myeloma effects.
- In vivo, CYT997 significantly prolonged survival in a murine model.
Conclusions:
- CYT997 exhibits promising pre-clinical efficacy against multiple myeloma.
- CYT997 warrants further investigation in clinical trials for MM treatment.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.